Study of the efficacy of intravenous tissue plasminogen activator in central retinal artery occlusion

International Journal of Stroke

Volumn 6, Issue 1, 2011, Pages 87-89

  Chen, Celia S ^a   Lee, Andrew W ^a   Campbell, Bruce ^b   Paine, Mark ^c   Lee, Tien ^a   Fraser, Clare ^d   Grigg, John ^d   Markus, Romesh ^e   Williams, Keryn ^a   Coster, Doug J ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

Author keywords

Central retinal artery occlusion; Outcome; Reperfusion; Thrombolysis; Visual acuity

Indexed keywords

PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLEEDING; CENTRAL RETINA ARTERY OCCLUSION; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VISUAL ACUITY;

ADULT; COMPUTER SECURITY; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PLASMINOGEN ACTIVATORS; RECOVERY OF FUNCTION; RETINAL ARTERY OCCLUSION; SAMPLE SIZE; THROMBOEMBOLISM; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VISION DISORDERS; VISION, OCULAR; VISUAL ACUITY; VISUAL FIELDS;

EID: 78650935007     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00545.x     Document Type: Article

References (21)

1. Rumelt S, Dorenboim Y, Rehany U. Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 1999; 128:733-8.
2. Hayreh SS, Zimmerman MB. Central Retinal Artery Occlusion: visual Outcome. Am J Ophthalmol 2005; 140:376-91.
3. Atebara NH, Carter GC, Cater J. Efficacy of anterior chamber paracentesis and carbogen in treating acute nonarteric central retinal artery occlusion. Ophthalmology 1995; 102:2029-35.
4. Karjalainen K. Occlusion of the central retinal artery and retinal branch arterioles. Acta Ophthalmol 1971; 109 (Suppl.): 1-96.
5. Mueller AJ, Neubauer AS, Schaller U, Kampik A. Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol 2003; 121:1377-81.
6. NINDS. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-8.
7. Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II Study: A Randomized Controlled Trial. JAMA 1999; 282:2003-11.
8. Waters IIRE, Mahaffey KW, Granger CB, Roe MT. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies. Am Heart J 2003; 146:958-68.
9. Schmidt DP, Schulte-Monting J, Schumacher M. Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. AJNR Am J Neuroradiol 2002; 23:1301-7.
10. Arnold M, Koerner U, Remonda L et al. Comparison of intra arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion. J Neurol Neurosurg Psychiatry 2005; 76:196-9.
11. Beatty S, Au-Eong KG. Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophtalmol 2000; 84:914-6.
12. Richard G, Lerche RC, Knospe V, Zeumer H. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology 1999; 106:768-73.
13. Schumacher M, Schmidt D, Wakhloo AK. Intra-arterial fibrinolytic therapy in central retinal artery occlusion. Neuroradiology 1993; 35:600-5.
14. Kattah JC, Wang DZ, Reddy C. Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion. Arch Ophthalmol 2002; 120:1234-6.
15. Fibrinolytic therapy Trialist Collaborative Group. Indications for fibrinolytic therapy in suspected myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343:311-21.
16. The GISSI Study Group. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction. Lancet 1990; 336:65-71.
17. Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology 1980; 87:75-8.
18. Aldrich E, Lee AW, Chen CS et al. Local intraarterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins hospital experience. Stroke 2008; 39:1746-50.
19. Feltgen N, Neubauer A, Jurklies B et al. Mutlicenter study of the european assessment group for lysis in the eye (EAGLE) for the treatment of central retinal artery occlusio: design issues and implications. Eagle study report no. 1. Graefes Arch Clin Exp Ophthalmol 2006; 244:950-6.
20. Biousse V, Calvetti O, Bruce BB, Newman NJ. Thrombolysis for central retinal artery occlusion. J Neuroophthalmol 2007; 27:215-30.
21. Derex L, Nighoghossian N. Intracerebral hemorrhage after Thrombolysis for Acute Ischemic Stroke. An update. J Neurol Neurosurg Psychiatry 2008; 79:1093-9.